Smart ECM
FADDoc Congress SrlEvento 485980 / Edizione 1

Respiration day - Chronic airway diseases and their comorbidities

FAD asincrona (7 crediti ECM) su BPCO, asma, bronchiectasie e malattie delle piccole vie aeree, con relatori internazionali. Destinata a medici pneumologi e clinici. Dal 20 luglio al 31 dicembre 2026.

Provider
Doc Congress SrlDoc Congress Srl (246)
Crediti ECM
7
Costo
Gratuito
Durata
7 ore
Date
20 luglio - 31 dicembre 2026

Razionale scientifico

The aim of the 2026 Edition of "Respiration Day" is to provide the view of where the Respiratory clinicians and researchers are and where they are heading in the field of chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis and their comorbidities, and the role of small airway diseases in these respiratory diseases. The main aim of the meeting is educational, and the speakers have been specifically invited to translate in their lectures the most important recent discoveries to the potential improvement of clinical practice. A significant proportion of time (40%) will be devoted to discussion. The Meeting is divided in 5 sessions. The first session will focus on the recent advancements in COPD and its comorbidities, and in particular the first lecture will focus on the need to better characterize the different phenotypes included under the umbrella of the term COPD, both in term of etiology and clinical presentation, early diagnosis, and active search of multimorbidity to improve the management of individual patients (Bhatt et al, 2025; Celli et al, 2022). The second lecture will be devoted to novel therapies for COPD, particularly the biologics, with the aim of improved comprehensive and personalized management (Agusti et al, 2025). The third lecture will focus on the major cardiovascular risk in patients with COPD, both in stable and during and in the aftermath of exacerbations of respiratory symptoms (Gale et al, 2025). The second session will focus on asthma as a disease of both central and peripheral airways (Siddiqui et mal, 2026), the need of integration of traditional pharmacological inhalation treatments with systemic agents and/or biologics (Porsbjerg et al, 2023), the third the ongoing research focused on mechanisms rather than clinical treatable traits (Gaberino et al, 2026). The third session will be devoted to the importance and impact of small airways dysfunction for chronic airway diseases, and in particular on the fundamental role of inhalers but also of their environmental impact, its complex impact on respiratory and non-respiratory components of chronic airway diseases, and last, but not least, how can AI help us to understand the role of small airways dysfunction. The fourth session will be devoted to the novel discoveries in the field of pathology of chronic airway diseases, and particularly the importance of mucus plugs, and mucociliary clearance. Finally the fifth session will be devoted to bronchiectasis that in the last 15 years has been discovered to represent not only a treatable trait of other chronic airway diseases but also an independent treatable disease (Burgel and Mall, 2026; Chalmer et al, 2025).

Programma

Modulo 1 — Chronic obstructive pulmonary disease (COPD) as pulmonary component of multimorbidity
  • 25'Novel approaches to the diagnosis and assessment of severity of multimorbid COPDSurya Bhatt
  • 25'Novel approaches to the pharmacologic management of multimorbid COPDBartolome Celli
  • 25'Cardiovascular risk in stable and exacerbated multimorbid COPDFilippo Crea
Modulo 2 — Asthma as a disease of central and peripheral airways
  • 25'Pulmonary pathology of asthma, COPD and chronic bronchitis: role of small airwaysGuy Brusselle
  • 25'Integrated pharmacologic and biologic treatment of severe asthmaMatteo Bonini
  • 25'Mechanism directed treatment in chronic airway diseasesKlaus Rabe
Modulo 3 — Small airways dysfunction in chronic airway diseases
  • 25'Early origins of asthma: What happens to the airways?Erika Von Mutius
  • 25'Pathophysiology of small airway diseases (SAD)Omar Usmani
  • 25'Artificial intelligence in chronic airway diseasesAlvar A Agusti
Modulo 4 — Mucus and mucociliary clearance in chronic airway diseases
  • 25'Clinical role of central and peripheral airway diseases in asthmaMaarten Van den Berge
  • 25'Mucus plugs in chronic airway diseasesAlejandro A. Diaz
  • 25'The pathobiology and treatment of mucus plugs in asthma and COPDJohn Fahy
Modulo 5 — Bronchiectasis as treatable trait of chronic airway diseases or as an independent disease entity
  • 25'Novel approaches to the diagnosis and assessment of severity of bronchiectasisStefano Aliberti
  • 25'Novel approaches to the pharmacologic management of bronchiectasisMichal Shteinberg
  • 25'Mechanism directed treatment approach: triple therapy in cystic fibrosisPierre Regis Burgel

Responsabili del corso

DOC CONGRESS SRL

Provider

ID Provider: N° 246

Città: Milano (MI)

Tipologia: Società, Agenzie Ed Enti Privati

Stato accreditamento: Standard - 2° Rinnovo

  • Gaetano Caramori

    Responsabile scientifico

    Specializzazione: Biologia Molecolare e Patologia / Malattie dell'Apparato Respiratorio

    Struttura: Università degli Studi di Parma, Italy

    Ruolo: Professore Ordinario di Malattie dell'Apparato Respiratorio presso il Dipartimento di Medicina e Chirurgia (DIMEC)

  • Dario Olivieri

    Responsabile scientifico

    Specializzazione: Tisiologia / Malattie Respiratorie

    Struttura: Università degli Studi di Parma, Italy

    Ruolo: Docente presso la Scuola di Specializzazione in Malattie Respiratorie e Dottorato di Ricerca in Fisiopatologia Respiratoria

Relatori e docenti

  • Alvar Agusti

    Relatore

    Specializzazione: Respiratory Medicine

    Struttura: University of Barcelona and Hospital Clinic, Barcelona, Spain

    Ruolo: Professor of Medicine at the University of Barcelona and senior consultant at Hospital Clinic

  • Stefano Aliberti

    Relatore

    Specializzazione: Malattie dell'Apparato Respiratorio

    Struttura: Humanitas University, Milan, Italy

    Ruolo: Direttore del Programma di Fellowship in Malattie dell'Apparato Respiratorio, Dipartimento di Scienze Biomediche

  • Surya Bhatt

    Relatore

    Specializzazione: Internal Medicine / Pulmonary, Allergy & Critical Care Medicine

    Struttura: University of Alabama, Birmingham, USA

    Ruolo: Professor of Medicine

  • Matteo Bonini

    Relatore

    Specializzazione: Medicina dello Sport / Malattie dell'Apparato Respiratorio

    Struttura: Università Cattolica del Sacro Cuore di Roma, Italy

    Ruolo: Professore Associato in Malattie dell'Apparato Respiratorio

  • Guy Brusselle

    Relatore

    Specializzazione: Respiratory Medicine

    Struttura: Ghent University, Belgium

    Ruolo: Head of the Department of Respiratory Medicine and Professor of Medicine

Domande frequenti

L'evento è accreditato per: Medico Chirurgo (Allergologia Ed Immunologia Clinica, Geriatria, Malattie Dell'apparato Respiratorio, Medicina Interna, Medicina Generale (Medici Di Famiglia), Medicina Del Lavoro E Sicurezza Degli Ambienti Di Lavoro).

Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti.

Scarica la app gratuita Smart ECM

Con l'app gratuita tieni sotto controllo i tuoi crediti ECM, cerchi qualsiasi corso ECM e lo puoi salvare nel tuo piano formativo. Disponibile per iOS e Android.

Scarica su App Store
QR code per scaricare l'app Smart ECM

Sei un provider ECM?

Contattaci per scoprire come possiamo collaborare.

Contattaci